NSW Health wants to amend its defence to an underpayments class action on behalf of 24,000 junior doctors, bringing claims that the lead applicant is […]
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal […]
A judge has set aside a subpoena that allegedly sought to âembarrass the New South Wales governmentâ, in lawsuits contesting compulsory COVID-19 vaccination orders made […]
An Australian generic drug manufacturer has struck back at patent lawsuit by Swiss pharmaceutical company Biogen, alleging a patent for MS drug Tecfidera is invalid […]
Avant Insurance has lost a bid to pause an order that it pay $371,000 in the legal costs of a surgeon facing a class action […]
Hundreds of women who suffered âchaos and devastationâ at the hands of former surgeon Emil Gayed will be entitled to compensation after class action law […]
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would […]
Botox maker Allergan has successfully challenged a Federal Court judgment dismissing its trade mark lawsuit against an Australian company selling topical creams as an alternative […]
Avant Insurance has launched an appeal of a Federal Court judgment ordering it to cover the defence costs of a surgeon facing a class action […]
Tens of thousands of hospital patients were put at risk when Medtronic unlawfully supplied a bone grafting kit to hospitals that was not registered on […]